Legal Representation
Attorney
Andrew Galway
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 2, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 2, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 13, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 13, 2007 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 13, 2007 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 15, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2007 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 15, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 22, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2006 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 22, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 25, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 31, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 11, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 14, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 9, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 5, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 14, 2005 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 5, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 5, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 10, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 10, 2005 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 9, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 21, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancers, infectious diseases, acne, gastrointestinal tract diseases, central nervous system diseases, auto-immune diseases, musco-skeletal disorders, endocrine diseases including diabetes, genito-urinary system diseases, respiratory diseases including asthma and chronic obstructive pulmonary disease, allergies, allergic rhinitis, ophthalmic diseases, obstetrical and gynecological diseases, neoplastic disorders, pain, inflammation, age-related disorders, migraines, obesity, immunological disorders, bacterial disorders, viral disorders, fungal disorders and pharmaceutical dressings for wound management and skin disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005